IsoRay Financial Statements From 2010 to 2024

ISRDelisted Stock  USD 0.38  0.01  2.70%   
IsoRay financial statements provide useful quarterly and yearly information to potential IsoRay Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on IsoRay financial statements helps investors assess IsoRay's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting IsoRay's valuation are summarized below:
IsoRay Inc does not presently have any fundamental trends for analysis.
Check IsoRay financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IsoRay main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . IsoRay financial statements analysis is a perfect complement when working with IsoRay Valuation or Volatility modules.
  
This module can also supplement various IsoRay Technical models . Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

IsoRay Beta Analysis

IsoRay's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current IsoRay Beta

    
  1.49  
Most of IsoRay's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IsoRay Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, IsoRay Inc has a Beta of 1.4906. This is 73.33% higher than that of the Biotechnology sector and 43.33% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

IsoRay Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining IsoRay's current stock value. Our valuation model uses many indicators to compare IsoRay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IsoRay competition to find correlations between indicators driving IsoRay's intrinsic value. More Info.
IsoRay Inc is currently regarded as number one stock in cash per share category among related companies. It is currently regarded as number one stock in working capital category among related companies reporting about  32,141,026  of Working Capital per Cash Per Share. . Comparative valuation analysis is a catch-all model that can be used if you cannot value IsoRay by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for IsoRay's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IsoRay's earnings, one of the primary drivers of an investment's value.

About IsoRay Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include IsoRay income statement, its balance sheet, and the statement of cash flows. IsoRay investors use historical funamental indicators, such as IsoRay's revenue or net income, to determine how well the company is positioned to perform in the future. Although IsoRay investors may use each financial statement separately, they are all related. The changes in IsoRay's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on IsoRay's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on IsoRay Financial Statements. Understanding these patterns can help to make the right decision on long term investment in IsoRay. Please read more on our technical analysis and fundamental analysis pages.
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in IsoRay Stock

If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators